Barayev Edward, Meshi Amit, Gershoni Assaf, Segal Ori, Dotan Assaf, Hadayer Amir, Schaap Fogler Michal, Ehrlich Rita, Gal-Or Orly
Department of Ophthalmology, Rabin Medical Center, Petah Tikvah, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Eur J Ophthalmol. 2023 Jul;33(4):1697-1705. doi: 10.1177/11206721221150535. Epub 2023 Jan 4.
To compare morphologic characteristics of type 1 macular neovascularization (MNV) flow pattern in treatment-naïve and previously treated patients with age-related macular degeneration (AMD) as assessed by optical coherence tomography angiography (OCTA).
Cross-sectional study.
Macular OCT angiography images were acquired using RTVue XR Avanti with AngioVue. Distinct morphologic biomarkers and quantifiable features of the neovascular membranes were studied on en-face projection images comparing treatment-naïve and previously treated patients.
The study included 68 eyes of 58 patients. Among them, 24 eyes were treatment-naïve, and the remaining eyes had received a mean of 19.6 injections. Immature lesions were more associated with treatment-naïve eyes and hyper-mature lesions were associated with previously treated eyes (p = 0.005). Tangle pattern was associated with treatment-naïve eyes (p = 0.013), whereas mature core vessels and sea fan pattern were associated more with previously treated eyes (p = 0.001 and p = 0.044, respectively). Vascular density of the neovascular membrane was higher in the treatment-naïve group (p = 0.036) and the average MNV area was similar between the 2 groups (p = 0.683).
Based on OCTA, morphologic biomarkers of type 1 MNV might be an indication of previous treatment. The MNV pattern can improve our understanding of its maturation under anti-VEGF treatment and might be valuable to better guide therapeutic decisions and provide more personalized care to patients with AMD.
通过光学相干断层扫描血管造影(OCTA)评估,比较初治和既往接受过治疗的年龄相关性黄斑变性(AMD)患者1型黄斑新生血管(MNV)血流模式的形态学特征。
横断面研究。
使用配备AngioVue的RTVue XR Avanti采集黄斑OCT血管造影图像。在正位投影图像上研究初治和既往接受过治疗的患者新生血管膜的不同形态生物标志物和可量化特征。
该研究纳入了58例患者的68只眼。其中,24只眼为初治,其余眼睛平均接受了19.6次注射。不成熟病变与初治眼更相关,而高度成熟病变与既往接受过治疗的眼相关(p = 0.005)。缠结模式与初治眼相关(p = 0.013),而成熟核心血管和海扇模式与既往接受过治疗的眼更相关(分别为p = 0.001和p = 0.044)。初治组新生血管膜的血管密度更高(p = 0.036),两组之间平均MNV面积相似(p = 0.683)。
基于OCTA,1型MNV的形态生物标志物可能提示既往治疗情况。MNV模式可以提高我们对抗VEGF治疗下其成熟过程的理解,可能有助于更好地指导治疗决策,并为AMD患者提供更个性化的护理。